Refresh
Exchange Announcement • 17 May 2022 00:33
Exchange Announcement • 17 Mar 2022 16:00
Exchange Announcement • 10 Mar 2022 03:19
Exchange Announcement • 10 Mar 2022 03:16
Exchange Announcement • 10 Mar 2022 03:15
ENTITY
Zogenix Inc (ZGNX US)
Zogenix Inc (ZGNX US)
2
Analysis
Health Care • United States
Zogenix, Inc. is a specialty pharmaceutical company with proprietary product candidates in late-stage development for the treatment of central nervous system disorders and pain. The Company's products candidates include a product that enables needle-free subcutaneous delivery of sumatriptan for the treatment of acute migraine.
more
x